期刊文献+

超高效液相色谱-串联质谱法同时测定抗鼻炎中成药及保健品中19种化学药物 被引量:6

Simultaneous Determination of 19 Chemical Drugs in Traditional Chinese Medicines and Health Products for Treating Rhinitis by UPLC-MS/MS
下载PDF
导出
摘要 目的建立同时测定抗鼻炎类中成药及保健品中添加的19种化学药物的超高效液相色谱-串联质谱分析方法。方法采用Waters ACQUITY UPLC BEH C18色谱柱(2.1 mm×100 mm,1.7μm),以0.1%甲酸乙腈溶液-0.1%甲酸溶液为流动相,梯度洗脱,流速0.3 m L·min-1,柱温35℃,选择电喷雾电离源正离子扫描(ESI+),多反应监测模式(MRM)进行检测。结果 19种化学药物在各自质量浓度范围内线性关系较好,相关系数均>0.995,低、中、高浓度水平平均回收率84.9%~111.1%,RSD均<5.2%,检测限0.03~0.78 ng·m L-1,定量限0.13~1.82 ng·m L-1。结论该方法简便、快速、准确,灵敏度高,可作为抗鼻炎类中成药及保健品中非法添加化学药物的检测方法。 Objective To establish a UPLC-MS/MS method for simultaneous determination of 19 chemical drugs in Traditional Chinese Medicines and health products for treating rhinitis. Methods Separation was performed on Waters ACQUITY UPLC BEH-C18 column( 2.1 mm×100 mm,1.7 μm) with 0.1% formic acid acetonitrile solution and 0.1% formic acid aqueous solution as the mobile phase by gradient elution.The flow rate was 0.3 m L·min-1.The column temperature was set at 35 ℃.The detection was performed by the positive ion electrospray ionization( ESI+) under multiple reactions monitoring( MRM)mode. Results The linear relationships of 19 chemical drugs were good in respective ranges with correlation coefficients higher than 0.995.The average recoveries of the low,medium,and high level were in the range of 84.9%-111.1%,and the RSDs were less than 5.2%.The limits of detection( LOD) and the limits of quantitation( LOQ) were in the range of 0.03-0.78 ng·m L-1 and 0.13-1.82 ng·m L-1,respectively. Conclusion The method is convenient,rapid,accurate,and sensitive,which can be used for the determination of chemical drugs added illegally in traditional Chinese medicines and health products for treating rhinitis.
出处 《医药导报》 CAS 北大核心 2018年第3期356-360,共5页 Herald of Medicine
关键词 抗鼻炎中成药 保健品 超高效液相色谱-串联质谱法 Anti-rhinitis Traditional Chinese Medicines Health products UPLC-MS/MS
  • 相关文献

参考文献8

二级参考文献74

  • 1郑立新.色甘酸钠治疗变应性鼻炎的体会[J].中国现代药物应用,2009,3(3). 被引量:3
  • 2董永成,杜士明,陈永顺,涂自良.中成药及保健品非法添加化学成分的类型、危害及对策[J].时珍国医国药,2006,17(8):1601-1602. 被引量:56
  • 3邱颖妲,王铁杰,李美芳,庞学斌,李军.液相色谱-串联四极杆质谱联用法测定减肥类药品及保健品中非法掺入酚酞的研究[J].药物分析杂志,2006,26(11):1609-1611. 被引量:18
  • 4国家药典委员会.中国药典[s].北京:化学工业出版社,2005.59-60.
  • 5Cobano~lu B, Toskala E, tiral A, et al. R~le of leuko- triene antagonisls and antihistamines in the treatment of allergic rhinitis [J]. Curt ,lllergg" Asthma Rep, 2013, 13 (2): 203-8.
  • 6I~hman JM, Blaiss MS. l~harmaeotherapy of allergic rhinitis[J]. Allergy Frontiers, 2010, 5: 19-28.
  • 7国家食品药品监督管理局执、№药师资格认证中心.国家执业药师资格考试应试指南药学专业知识(一)[M].北京:中国医药科技出版社,2013:274.302-4.
  • 8Bousquet J, Khaltaev N, Cruz A A, el al. Allergic rhinitis and its impact on asyhma (AtrIA) 2008 update (in collaboration with tile World Health Organization, GAZLEN and AllerGen)[J]. Allergy, 2008, 63(Suppl 86):$-16.
  • 9Sheth K.Evaluating the safety of intranasal steroids in the treatment of allergic rhinitis[J]. Allergy Asthma Clin lmmunol, 2008, 4(3): 125-9.
  • 10Meltzer EO, Tripathy I, M6spero JF, et al. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6~11 years with allergic rhinitis[J]. Clin Drug Investig, 2009, 29(2): 79-86.

共引文献91

同被引文献75

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部